|
Market Closed -
Nasdaq
00:30:00 21/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.160 USD | -10.77% |
|
-12.12% | -83.02% |
| Market Cap | 20.07M 18.28M 16.85M 15.32M 28.75M 1.86B 30.21M 205M 81.49M 1.02B 75.31M 73.72M 3.19B | P/E 2024 |
-0.07x | P/E 2025 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 2.26M 2.06M 1.9M 1.72M 3.24M 209M 3.4M 23.07M 9.17M 114M 8.48M 8.3M 359M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
98.26% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAZ | Delayed | |
| RNAZ | Real-time |
Last Transcript: TransCode Therapeutics, Inc.
| 1 day | -10.77% | ||
| 1 week | -12.12% | ||
| Current month | -28.83% | ||
| 1 month | -30.12% | ||
| 3 months | -59.58% | ||
| 6 months | -81.03% | ||
| Current year | -83.02% |
| 1 week | 1.01 | 1.53 | |
| 1 month | 1.01 | 1.91 | |
| Current year | 1.01 | 12.6 | |
| 1 year | 1.01 | 12.6 | |
| 3 years | 1.01 | 17,245.52 | |
| 5 years | 1.01 | 2,313,719.69 | |
| 10 years | 1.01 | 5,174,452.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Calais
CEO | Chief Executive Officer | 67 | 06/10/2025 |
Zdravka Medarova
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/10/2021 |
John Tattory
DFI | Director of Finance/CFO | 61 | 10/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Calais
CHM | Chairman | 67 | 18/02/2021 |
Erik Manting
BRD | Director/Board Member | 54 | 20/12/2020 |
Magda Marquet
BRD | Director/Board Member | 67 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 A | Free | Chief Executive Officer | 185,000 | 1.0927% | ||
| 8/3/26 A | Conversion | Company | 13,834,441 | 81.7120% | ||
| 7/27/26 A | Other | Company | 300,040 | 1.7722% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -10.77% | -12.12% | -86.57% | -99.99% | 20.07M | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.89B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -2.31% | -2.31% | +21.10% | +152.49% | 40B | |
| Weighted average by Cap. | -1.48% | -1.85% | +31.83% | +155.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -16.75M -15.26M -14.06M -12.79M -24M -1.55B -25.22M -171M -68.02M -847M -62.86M -61.54M -2.66B | -34.66M -31.57M -29.09M -26.46M -49.64M -3.21B -52.17M -354M -141M -1.75B -130M -127M -5.5B |
| Net Debt | -5.77M -5.26M -4.84M -4.41M -8.27M -535M -8.69M -58.97M -23.44M -292M -21.66M -21.2M -916M | -17.81M -16.22M -14.95M -13.6M -25.51M -1.65B -26.81M -182M -72.32M -901M -66.84M -65.43M -2.83B |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | $1.160 | -10.77% | 60,672 |
| 19/11/26 | $1.300 | -3.35% | 17,105 |
| 18/11/26 | $1.345 | -4.61% | 18,086 |
| 17/11/26 | $1.410 | +4.44% | 36,749 |
| 16/11/26 | $1.350 | +2.27% | 50,416 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- RNAZ Stock
Select your edition
All financial news and data tailored to specific country editions
















